Europe Light Therapy Market

Europe Light Therapy Market Size (2024 to 2029)

The European light therapy market is predicted to value USD 0.41 billion by 2029 from USD 0.32 billion in 2024, registering a CAGR of 4.79% during the forecast period.

The light therapy market in the European region is primarily driven by the increased frequency of skin problems and the growing acceptability of therapy. The availability of goods through online platforms and growing knowledge among end-users about adopting light treatment solutions to avoid depression drive growth in the European light therapy market. The growing need for non-invasive treatments and developing client preferences for light therapy complements the industry environment to a substantial degree. Industry players are focusing on inorganic operations such as acquisitions and partnerships to expand their product range and strengthen their position in the European market, expected to drive market growth. Furthermore, because of the requirement for enhanced comfort and precision when executing therapeutic operations, light therapy devices that are portable, lightweight, and handheld are becoming increasingly popular in healthcare settings.

Light treatment's lower cost compared to laser surgery and people's growing awareness of their aesthetic appearance are expected to fuel demand in the coming years. Furthermore, due to expanded utilization across a wide range of healthcare applications, the European light therapy industry has witnessed substantial expansion in recent years. These services might range from treating a variety of skin disorders to ensuring the psychological well-being of patients.

The use of light therapy in individuals with drug-resistant non-seasonal depression might result in mania, a hyperactive state. Such difficulties are projected to limit the growth of the European light therapy market throughout the forecast period. Light therapy market expansion in the European region is further predicted to be hampered by a lack of understanding about the therapy and a lack of money put in research by companies. Furthermore, the unwillingness of people to utilize light treatment due to the associated side effects is projected to restrict the market growth. Light therapy can cause headaches, burning sensations, eye pain, itching, and nausea. This issue may pose a threat to the expansion of the light treatment sector in the near future.

This research report on the European light therapy market has been segmented and sub-segmented into the following categories.

By Product:

• Lightbox
• Floor and desk lamps
• Light visor
• Handheld devices for skin treatment (HDST)
• Dawn simulator
• Light therapy bulbs
• Others

By Application:

• Psoriasis
• Vitiligo
• Eczema
• Acne Vulgaris
• Seasonal Affective Disorder (SAD)
• Sleeping Disorders
• Others

By Light Type:

• Blue Light
• Red Light
• White Light
• Others

By End-User:

• Homecare Settings
• Dermatology Clinics
• Others

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, the European region is progressing at a healthy rate and accounts for a promising share in the global market during the forecast period due to rising personal disposable income and improved healthcare facilities. In addition, the existence of well-known firms will further aid the market's expansion. Therefore, the market in this area is predicted to grow as the benefits of this therapy, such as cellular regeneration and improved blood circulation, become more widely known. Furthermore, a rise in patient demand for less intrusive procedures and technical advancements in light treatment will help the market grow more quickly in the future. Moreover, an increase in the frequency of skin illnesses and manufacturers' continuing investment in releasing novel products are driving the European market expansion.

The UK is likely to lead the European Light Therapy market during the forecast period. As a result, key stakeholders in the SAD industry seek new revenue streams. According to a National Health Service study, SAD affects 1 in 15 people from September to April.

Only 5% of research participants stated they were delighted in the winter, compared to 46% in the summer. Additionally, more than half of those polled said they were less happy between November and February, with nearly three out of five citing a lack of sunlight as a factor. Furthermore, more than a third of them reported that not getting enough sleep during the winter increased their SAD levels.

KEY MARKET PLAYERS

Companies playing a pivotal role in the European light therapy market profiled in this report are Aura Daylight, Beurer, BioPhotas, Chal-Tec, Koninklijke Philips, Lucimed, Lumie, Northern Light Technology, Nature Bright, and Neutrogena.